Oligon catheter cuts infections:
This article was originally published in Clinica
Implemed (US) has launched the Olimpicc central venous catheter (PICC), in the UK. The peripherally inserted catheter is made with Oligon anti-infection polymer technology. The company says nosocomial infections cost the US healthcare system over $11,000 million annually, while 3 million patients contract nosocomial infections every year in Europe. In developing countries this figure could be five to ten times higher. By preventing bacterial colonisation of PICCS, the "anti-infective" technology incorporated into Olimpicc "can mean improved patient outcomes and lower healthcare costs," Implemed claims. Launch of the Olimpicc throughout Europe, the Far East, and the US is also anticipated.